Stereotactic body radiotherapy in pancreatic adenocarcinoma.
de la Pinta C.
Hepatobiliary Pancreat Dis Int. 2024 Feb;23(1):14-19. doi: 10.1016/j.hbpd.2023.03.002. Epub 2023 Mar 16.
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview.
Matsuo Y.
Curr Oncol. 2023 Feb 18;30(2):2493-2500. doi: 10.3390/curroncol30020190.
Stereotactic body radiotherapy for spinal metastases: a review.
Guo L, Ke L, Zeng Z, Yuan C, Wu Z, Chen L, Lu L.
Med Oncol. 2022 May 23;39(5):103. doi: 10.1007/s12032-021-01613-8.
Stereotactic body radiotherapy for oligometastatic disease: current evidence and future perspectives.
Imano N.
Int J Clin Oncol. 2025 Aug;30(8):1505-1521. doi: 10.1007/s10147-025-02776-4. Epub 2025 May 17.
[Stereotactic body radiotherapy: Passing fad or revolution?].
Vallard A, Vial N, Jmour O, Rehailia-Blanchard A, Trone JC, Sotton S, Daguenet E, Guy JB, Magné N.
Bull Cancer. 2020 Feb;107(2):244-253. doi: 10.1016/j.bulcan.2019.09.011. Epub 2019 Dec 19.
Stereotactic body radiotherapy for lung cancer: a review.
Nagata Y, Kimura T.
Jpn J Clin Oncol. 2025 Dec 3;55(12):1316-1325. doi: 10.1093/jjco/hyaf142.
Stereotactic Body Radiotherapy for Liver Metastases.
Goodman KA, Kavanagh BD.
Semin Radiat Oncol. 2017 Jul;27(3):240-246. doi: 10.1016/j.semradonc.2017.02.004. Epub 2017 Feb 20.
Stereotactic body radiotherapy.
Kollar L, Rengan R.
Semin Oncol. 2014 Dec;41(6):776-89. doi: 10.1053/j.seminoncol.2014.09.022. Epub 2014 Oct 7.
Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future Perspectives.
Vandaele S, Albersen M, Beuselinck B, Goffin K, Vandecaveye V, Vandermeulen H, Berghen C.
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251357344. doi: 10.1177/15330338251357344. Epub 2025 Jul 17.
[Stereotactic body radiotherapy of primary liver tumours: Indications and new techniques].
Bordeau K, Michalet M, Keskes A, Debrigode C, Azria D, Riou O.
Cancer Radiother. 2022 Oct;26(6-7):851-857. doi: 10.1016/j.canrad.2022.06.031. Epub 2022 Aug 30.
